Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,969,231
-
Total 13F shares
-
358,561
-
Share change
-
+15,448
-
Total reported value
-
$1,881,000
-
Price per share
-
$5.17
-
Number of holders
-
11
-
Value change
-
+$104,639
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2020
As of 30 Jun 2020 Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 358,561 shares of stock of the company.
Largest 10 holders included Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, Tower Research Capital LLC (TRC), FNY Investment Advisers, LLC, Covington Capital Management, TRUE Private Wealth Advisors, UBS Group AG, and Private Advisor Group, LLC.
This table shows 11 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.